hi i just got my first dose yesterday, things seemed well enough for 6 hours, then it all started, i started to feel very very cold, and then starting shaking, "o well, just a common side effect" i thought, so i went to bed, all seemed well enough, but i woke up around 3 am and was shaking uncontrollably, and i could hardly move are wanted to since i felt so depressed. i stood up and all my joints and back and bones hurt so bad i felt like crying, now it is day two, and i can hardly move, everything is sore, i am a guy who can handle the worst pain you can think of, yet this is nearly killing me, i have to take another shot in 4 hours, i cry just thinking about what this is going to do to me.
if you have any awnsers about what i should do plz inform me.
p.s. i am taking .20 ml of interferon everyday, i think it is alpha-2b. also i am taking it for Gorhams Disease (srry its not hep c, but there is so much infomation on this site, and u seem so educated)
By interfering with RNA, drug company Santaris may have launched a new generation of drugs. Following a successful animal trial, an unusual new drug has sparked interest due to its ability to lower cholesterol and block the Hepatitis C virus.
A drug that can lower cholesterol levels and prevent the liver from being attacked by the hepatitis C virus has come a step closer following a successful trial on laboratory animals.
The drug works in an unusual way by interfering with the natural genetic mechanism in the cells of the liver that keeps cholesterol levels high and – coincidentally – allows the hepatitis virus to replicate within the organ. The study, which was carried out on African green monkeys, lowered cholesterol levels by up to 40 per cent over three months with the help of just three intra-venous injections given over five days at the start of the trial.
Each injection contained a watery solution of a short, single-stranded molecule of RNA – a close relative of DNA – which found its way to the liver and bonded with a similar type of RNA which is found within the organ's cells. This prevented the natural RNA from working normally, boosting the activity of certain genes, which lowered cholesterol and blocked the hepatitis C virus.
The study, published in Nature, was carried out by the Danish drug company Santaris. Scientists believe the findings support the idea of a new generation of drugs based on the ability to interfere with the natural functions of RNA.
Human trials of the new drug are expected to begin later this year.
